Effect of transforming growth factor α overexpression on urogenital organ development in mouse

Differentiation

Volumn 80, Issue 2-3, 2010, Pages 82-88

  Yoshio, Yuko ^a   Ishii, Kenichiro ^a,b   Arase, Shigeki ^a   Hori, Yasuhide ^a   Nishikawa, Kohei ^a   Soga, Norihito ^a   Kise, Hideaki ^a   Arima, Kiminobu ^a   Sugimura, Yoshiki ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY   (Japan)

Author keywords

Basal epithelial cell; Transforming growth factor ; Transgenic mouse; Urogenital organ

Indexed keywords

DNA; KI 67 ANTIGEN; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER DISTENSION; BLADDER MUCOSA; BLADDER NECK STENOSIS; CARCINOGENESIS; CONTROLLED STUDY; EPIDIDYMIS; EPITHELIUM HYPERPLASIA; FIBROSIS; HISTOPATHOLOGY; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; KIDNEY PARENCHYMA; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; ORGANOGENESIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE; PROTEIN EXPRESSION; SEMINAL VESICLE; STROMA; TESTIS; TRANSGENIC MOUSE; URETHRA; UROGENITAL SYSTEM; UROGENITAL TRACT CANCER; WILD TYPE;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR ALPHA; UROGENITAL SYSTEM;

MUS; MUS MUSCULUS;

EID: 77957296793     PISSN: 03014681     EISSN: 14320436     Source Type: Journal    
DOI: 10.1016/j.diff.2010.06.006     Document Type: Article

References (52)

1. Abbott B.D., Lin T.M., Rasmussen N.T., Albrecht R.M., Schmid J.E., Peterson R.E. Lack of expression of EGF and TGF-alpha in the fetal mouse alters formation of prostatic epithelial buds and influences the response to TCDD. Toxicol. Sci. 2003, 76:427-436.
2. Baker J., Hardy M.P., Zhou J., Bondy C., Lupu F., Bellve A.R., Efstratiadis A. Effects of an Igf1 gene null mutation on mouse reproduction. Mol. Endocrinol. 1996, 10:903-918.
3. Baskin L.S., Hayward S.W., Sutherland R.A., DiSandro M.J., Thomson A.A., Goodman J., Cunha G.R. Mesenchymal-epithelial interactions in the bladder. World J. Urol. 1996, 14:301-309.
4. Baskin L.S., Hayward S.W., Sutherland R.A., DiSandro M.S., Thomson A.A., Cunha G.R. Cellular signaling in the bladder. Front Biosci. 1997, 2:d592-595.
5. Baskin L.S., Sutherland R.S., Thomson A.A., Hayward S.W., Cunha G.R. Growth factors and receptors in bladder development and obstruction. Lab Invest. 1996, 75:157-166.
6. Ciana P., Ghisletti S., Mussi P., Eberini I., Vegeto E., Maggi A. Estrogen receptor alpha, a molecular switch converting transforming growth factor-alpha-mediated proliferation into differentiation in neuroblastoma cells. J. Biol. Chem. 2003, 278:31737-31744.
7. Culig Z., Hobisch A., Cronauer M.V., Radmayr C., Hittmair A., Zhang J., Thurnher M., Bartsch G., Klocker H. Regulation of prostatic growth and function by peptide growth factors. Prostate 1996, 28:392-405.
8. Cunha G.R., Cooke P.S., Kurita T. Role of stromal-epithelial interactions in hormonal responses. Arch. Histol. Cytol. 2004, 67:417-434.
9. De Miguel P., Royuela, Bethencourt R., Ruiz A., Fraile B., Paniagua R. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates. Cytokine 1999, 11:722-727.
10. DeHaan A.M., Wolters N.M., Keller E.T., Ignatoski K.M. EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling. Prostate 2009, 69:528-537.
11. DiGiovanni J., Kiguchi K., Frijhoff A., Wilker E., Bol D.K., Beltran L., Moats S., Ramirez A., Jorcano J., Conti C. Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice. Proc. Natl. Acad. Sci. USA 2000, 97:3455-3460.
12. Foster B.A., Evangelou A., Gingrich J.R., Kaplan P.J., DeMayo F., Greenberg N.M. Enforced expression of FGF-7 promotes epithelial hyperplasia whereas a dominant negative FGFR2iiib promotes the emergence of neuroendocrine phenotype in prostate glands of transgenic mice. Differentiation 2002, 70:624-632.
13. Goldstein A.S., Lawson D.A., Cheng D., Sun W., Garraway I.P., Witte O.N. Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc. Natl. Acad. Sci. USA 2008, 105:20882-20887.
14. Gordon M.S., Hussey M., Nagle R.B., Lara P.N., Mack P.C., Dutcher J., Samlowski W., Clark J.I., Quinn D.I., Pan C.X., Crawford D. Phase II study of erlotinib in patients with locally advanced or metastatic papillary histology renal cell cancer: SWOG S0317. J. Clin. Oncol. 2009, 27:5788-5793.
15. Gudjonsson T., Adriance M.C., Sternlicht M.D., Petersen O.W., Bissell M.J. Myoepithelial cells: their origin and function in breast morphogenesis and neoplasia. J. Mammary Gland Biol. Neoplasia 2005, 10:261-272.
16. Haughney P.C., Hayward S.W., Dahiya R., Cunha G.R. Species-specific detection of growth factor gene expression in developing murine prostatic tissue. Biol. Reprod. 1998, 59:93-99.
17. Huitfeldt H.S., Skarpen E., Lindeman B., Becher R., Thrane E.V., Schwarze P.E. Differential distribution of Met and epidermal growth factor receptor in normal and carcinogen-treated rat liver. J. Histochem. Cytochem. 1996, 44:227-233.
18. Hursting S.D., Perkins S.N., Lavigne J.A., Beltran L., Haines D.C., Hill H.L., Alvord W.G., Barrett J.C., DiGiovanni J. Urothelial overexpression of insulin-like growth factor-1 increases susceptibility to p-cresidine-induced bladder carcinogenesis in transgenic mice. Mol. Carcinog. 2009, 48:671-677.
19. Itoh N., Patel U., Skinner M.K. Developmental and hormonal regulation of transforming growth factor-alpha and epidermal growth factor receptor gene expression in isolated prostatic epithelial and stromal cells. Endocrinology 1998, 139:1369-1377.
20. Jacobs M.A., Wotkowicz C., Baumgart E.D., Neto B.S., Rieger-Christ K.M., Bernier T., Cohen M.S., Libertino J.A., Summerhayes I.C. Epidermal growth factor receptor status and the response of bladder carcinoma cells to erlotinib. J. Urol. 2007, 178:1510-1514.
21. Jhappan C., Stahle C., Harkins R.N., Fausto N., Smith G.H., Merlino G.T. TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 1990, 61:1137-1146.
22. Kaplan P.J., Leav I., Greenwood J., Kwan P.W., Ho S.M. Involvement of transforming growth factor alpha (TGFalpha) and epidermal growth factor receptor (EGFR) in sex hormone-induced prostatic dysplasia and the growth of an androgen-independent transplantable carcinoma of the prostate. Carcinogenesis 1996, 17:2571-2579.
23. Khazaie K., Schirrmacher V., Lichtner R.B. EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev. 1993, 12:255-274.
24. Konno-Takahashi N., Takeuchi T., Nishimatsu H., Kamijo T., Tomita K., Schalken J.A., Teshima S., Kitamura T. Engineered FGF-2 expression induces glandular epithelial hyperplasia in the murine prostatic dorsal lobe. Eur. Urol. 2004, 46:126-132.
25. Kurita T., Medina R.T., Mills A.A., Cunha G.R. Role of p63 and basal cells in the prostate. Development 2004, 131:4955-4964.
26. Lager D.J., Slagel D.D., Palechek P.L. The expression of epidermal growth factor receptor and transforming growth factor alpha in renal cell carcinoma. Mod. Pathol. 1994, 7:544-548.
27. Longhurst P.A. In vitro rat bladder function after neonatal estrogenization. J. Urol. 2002, 168:2695-2699.
28. Lowden D.A., Lindemann G.W., Merlino G., Barash B.D., Calvet J.P., Gattone V.H. Renal cysts in transgenic mice expressing transforming growth factor-alpha. J. Lab. Clin. Med. 1994, 124:386-394.
29. Montironi R., Mazzucchelli R., Stramazzotti D., Scarpelli M., Lopez Beltran A., Bostwick D.G. Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression. J. Clin. Pathol. 2005, 58:290-296.
30. Nabhan C., Lestingi T.M., Galvez A., Tolzien K., Kelby S.K., Tsarwhas D., Newman S., Bitran J.D. Erlotinib has moderate single-agent activity in chemotherapy-naive castration-resistant prostate cancer: final results of a phase II trial. Urology 2009, 74:665-671.
31. Nguyen H.Q., Danilenko D.M., Bucay N., DeRose M.L., Van G.Y., Thomason A., Simonet W.S. Expression of keratinocyte growth factor in embryonic liver of transgenic mice causes changes in epithelial growth and differentiation resulting in polycystic kidneys and other organ malformations. Oncogene 1996, 12:2109-2119.
32. Ogura Y., Ishii K., Kanda H., Kanai M., Arima K., Wang Y., Sugimura Y. Bisphenol A induces permanent squamous change in mouse prostatic epithelium. Differentiation 2007, 75:745-756.
33. Pezaro C., Rosenthal M.A., Gurney H., Davis I.D., Underhill C., Boyer M.J., Kotasek D., Solomon B., Toner G.C. An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancer. Am. J. Clin. Oncol. 2009, 32:338-341.
34. Risbridger G., Wang H., Young P., Kurita T., Wang Y.Z., Lubahn D., Gustafsson J.A., Cunha G. Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium. Dev. Biol. 2001, 229:432-442.
35. Robinson E.J., Neal D.E., Collins A.T. Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium. Prostate 1998, 37:149-160.
36. Ruan W., Powell-Braxton L., Kopchick J.J., Kleinberg D.L. Evidence that insulin-like growth factor I and growth hormone are required for prostate gland development. Endocrinology 1999, 140:1984-1989.
37. Sandgren E.P., Luetteke N.C., Palmiter R.D., Brinster R.L., Lee D.C. Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 1990, 61:1121-1135.
38. Sandgren E.P., Schroeder J.A., Qui T.H., Palmiter R.D., Brinster R.L., Lee D.C. Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice. Cancer Res. 1995, 55:3915-3927.
39. Santini D., Ceccarelli C., Tardio M.L., Taffurelli M., Marrano D. Immunocytochemical expression of epidermal growth factor receptor in myoepithelial cells of the breast. Appl. Immunohistochem. Mol. Morphol. 2002, 10:29-33.
40. Shuch B., Mikhail M., Satagopan J., Lee P., Yee H., Chang C., Cordon-Cardo C., Taneja S.S., Osman I. Racial disparity of epidermal growth factor receptor expression in prostate cancer. J. Clin. Oncol. 2004, 22:4725-4729.
41. Signoretti S., Waltregny D., Dilks J., Isaac B., Lin D., Garraway L., Yang A., Montironi R., McKeon F., Loda M. p63 is a prostate basal cell marker and is required for prostate development. Am. J. Pathol. 2000, 157:1769-1775.
42. Slovin S.F., Kelly W.K., Wilton A., Kattan M., Myskowski P., Mendelsohn J., Scher H.I. Anti-epidermal growth factor receptor monoclonal antibody cetuximab plus doxorubicin in the treatment of metastatic castration-resistant prostate cancer. Clin. Genitourin Cancer 2009, 7:E77-82.
43. Strauss L., Paranko J., Salmi S., Streng T., Launonen A., Morris N., Lakkakorpi J., Makela S., Santti R. Distribution of collagen XII and XIV in the bladder wall of the male rat with outlet obstruction. J. Urol. 2000, 163:1304-1308.
44. Streng T., Launonen A., Salmi S., Saarinen N., Talo A., Makela S., Santti R. Nontraumatic urethral dyssynergia in neonatally estrogenized male rats. J. Urol. 2001, 165:1305-1309.
45. Sugimura Y., Cunha G.R., Donjacour A.A. Morphogenesis of ductal networks in the mouse prostate. Biol. Reprod. 1986, 34:961-971.
46. Sugimura Y., Foster B.A., Hom Y.K., Lipschutz J.H., Rubin J.S., Finch P.W., Aaronson S.A., Hayashi N., Kawamura J., Cunha G.R. Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate. Int. J. Dev. Biol. 1996, 40:941-951.
47. Thogersen V.B., Jorgensen P.E., Sorensen B.S., Bross P., Orntoft T., Wolf H., Nexo E. Expression of transforming growth factor alpha and epidermal growth factor receptor in human bladder cancer. Scand. J. Clin. Lab. Invest. 1999, 59:267-277.
48. Thomson A.A. Role of androgens and fibroblast growth factors in prostatic development. Reproduction 2001, 121:187-195.
49. Timms B.G., Howdeshell K.L., Barton L., Bradley S., Richter C.A., vom Saal F.S. Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. Proc. Natl. Acad. Sci. USA 2005, 102:7014-7019.
50. Tunn U., Senge T., Schenck B., Neumann F. Biochemical and histological studies on prostates in castrated dogs after treatment with androstanediol, oestradiol and cyproterone acetate. Acta. Endocrinol. (Copenhagen) 1979, 91:373-384.
51. Waladali W., Luo Y., Li W.S., Zheng M.X., Hu Q.L. 17Beta-estradiol affects the proliferation and apoptosis of rat bladder neck smooth muscle cells by modulating cell cycle transition and related proteins. World J. Urol. 2009, 27:241-248.
52. Yang A., Kaghad M., Wang Y., Gillett E., Fleming M.D., Dotsch V., Andrews N.C., Caput D., McKeon F. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 1998, 2:305-316.